Read More Pharma Industry News PvP Biologics launches Phase 1 trials for celiac disease candidate Kuma062 PvP Biologics, a US-based pharmaceutical company, has recently begun two phase 1 clinical trials to assess the safety,… bypharmanewsdailySeptember 8, 2018
